Press Releases

01.08.2018

Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available ‘Big Data’ Human Sequencing Resource with UK Biobank

01.08.2018

Alexandria Venture Investments Launches the Alexandria Seed Capital Platform, a Novel and Innovative Seed-Stage Life Science Funding Model and a Natural Extension of Alexandria LaunchLabs

01.08.2018

Pfizer Inc. Announces Expiration and Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents

01.08.2018

Pfizer Establishes New Partnering Model for Early-Stage Academic Research

01.05.2018

Distributed Bio Announces SuperHuman Platform License Agreement with Pfizer Inc.

01.05.2018

Distributed Bio Announces SuperHuman Platform License Agreement with Pfizer Inc.

01.04.2018

Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates

01.04.2018

Berkeley Lights Announces Research Collaboration and License Agreement with Pfizer

01.03.2018

Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS

12.22.2017

FDA Approves SGLT2 Inhibitor STEGLATRO™ (ertugliflozin) and Fixed-Dose Combination STEGLUJAN™ (ertugliflozin and sitagliptin) for Adults with Type 2 Diabetes

12.21.2017

FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma

12.19.2017

U.S. FDA Approves Pfizer’s BOSULIF® (bosutinib) for the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML)